DYRK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.683000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.391200E-01
Normal-vs-Stage2
9.687000E-01
Normal-vs-Stage3
3.222200E-01
Normal-vs-Stage4
4.386400E-01
Stage1-vs-Stage2
5.698800E-01
Stage1-vs-Stage3
6.284000E-01
Stage1-vs-Stage4
2.218200E-01
Stage2-vs-Stage3
3.686000E-01
Stage2-vs-Stage4
4.095000E-01
Stage3-vs-Stage4
1.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.602800E-01
Normal-vs-AfricanAmerican
5.984000E-01
Normal-vs-Asian
4.241400E-01
Caucasian-vs-AfricanAmerican
2.781400E-01
Caucasian-vs-Asian
2.221600E-01
AfricanAmerican-vs-Asian
1.199630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.455000E-01
Normal-vs-Female
8.578600E-01
Male-vs-Female
3.562800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.480400E-01
Normal-vs-Age(41-60Yrs)
5.990600E-01
Normal-vs-Age(61-80Yrs)
8.067800E-01
Normal-vs-Age(81-100Yrs)
3.257800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.530800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.740200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.882000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.519600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.020200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.141400E-01
Normal-vs-Daily Drinker
3.340800E-01
Normal-vs-Weekly Drinker
5.394600E-01
Normal-vs-Occasional Drinker
6.428600E-01
Normal-vs-Social Drinker
9.054000E-01
Non Drinker-vs-Daily Drinker
3.650200E-01
Non Drinker-vs-Weekly Drinker
8.830600E-01
Non Drinker-vs-Occasional Drinker
5.485800E-02
Non Drinker-vs-Social Drinker
2.534200E-01
Daily Drinker-vs-Weekly Drinker
5.254600E-01
Daily Drinker-vs-Occasional Drinker
1.657850E-02
Daily Drinker-vs-Social Drinker
6.729500E-02
Weekly Drinker-vs-Occasional Drinker
1.026580E-01
Weekly Drinker-vs-Social Drinker
2.638000E-01
Occasional Drinker-vs-Social Drinker
4.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.651630E-01
Normal-vs-Grade 2
4.609800E-02
Normal-vs-Grade 3
4.430300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.917400E-01
Grade 1-vs-Grade 3
3.898200E-01
Grade 1-vs-Grade 4
1.651630E-01
Grade 2-vs-Grade 3
8.755000E-01
Grade 2-vs-Grade 4
4.609800E-02
Grade 3-vs-Grade 4
4.430300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.440200E-01
Normal-vs-NonDiabetic
8.373600E-01
Diabetic-vs-NonDiabetic
9.796600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.776600E-01
Normal-vs-NoPancreatitis
9.122400E-01
Pancreatitis-vs-NoPancreatitis
3.593400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.530800E-01
Normal-vs-N1
9.227400E-01
N0-vs-N1
1.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.859000E-01
Normal-vs-TP53-NonMutant
9.139600E-01
TP53-Mutant-vs-TP53-NonMutant
8.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
